缩写名/全名 |
BIODRUGS
BIODRUGS |
||||||||||||||||||||||||
ISSN号 | 1173-8804 | ||||||||||||||||||||||||
研究方向 | 医学-免疫学 | ||||||||||||||||||||||||
影响因子 | 2015:2.867, 2016:2.835, 2017:3.825, 2018:4.903, 2019:5.313, | ||||||||||||||||||||||||
出版国家 | NEW ZEALAND | ||||||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||||||
年文章数 | 55 | ||||||||||||||||||||||||
出版年份 | 1997 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | >12周,或约稿 |
||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||
投稿链接 | http://www.editorialmanager.com/adis/ | ||||||||||||||||||||||||
投稿官网 | http://adisonline.com/biodrugs/pages/default.aspx | ||||||||||||||||||||||||
h-index | 60 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-8804%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects Author: Tan Zhang, Guihong Chen, Chang Liu, Li’an Zu, Qi Wang, Yitong Wang, Jie Lv, Youzhong An, Lihou Dong, Huiyang Cheng, Shengbin Ren, Qian Wang, Qingshan Zheng, Haifeng Song, Yi Fang Journal: BIODRUGS, 2018, Vol., , DOI:10.1007/s40259-018-0326-x DOI |
2. | A New Strategy for Treatment of Liver Fibrosis Author: Shao-Long Chen, Ming-Hua Zheng, Ke-Qing Shi, Tao Yang, Yong-Ping Chen Journal: BIODRUGS, 2012, Vol.27, 25-34, DOI:10.1007/s40259-012-0005-2 DOI |
3. | Erratum to: Bacteriophage Polysaccharide Depolymerases and Biomedical Applications Author: Jianlong Yan, Jinxiao Mao, Jianping Xie Journal: BIODRUGS, 2014, Vol.28, 323-323, DOI:10.1007/s40259-014-0092-3 DOI |
4. | Bacteriophage Polysaccharide Depolymerases and Biomedical Applications Author: Jianlong Yan, Jiaoxiao Mao, Jianping Xie Journal: BIODRUGS, 2013, Vol.28, 265-274, DOI:10.1007/s40259-013-0081-y DOI |
5. | EXTEND II: An Open-Label Phase III Multicentre Study to Evaluate Efficacy and Safety of Ranibizumab in Chinese Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Author: Jialiang Zhao, Xiaoxin Li, Shibo Tang, Gezhi Xu, Xun Xu, Feng Zhang, Meixia Zhang, Jila Shamsazar, Stefan Pilz, Annette Nieweg Journal: BIODRUGS, 2014, Vol.28, 527-536, DOI:10.1007/s40259-014-0106-1 DOI |
6. | miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3 Author: Lei Shi, Yi Wan, Guan Sun, Shuguang Zhang, Zhimin Wang, Yanjun Zeng Journal: BIODRUGS, 2013, Vol.28, 41-54, DOI:10.1007/s40259-013-0053-2 DOI |
7. | 4-Hydroxyisoleucine: A Potential New Treatment for Type 2 Diabetes Mellitus Author: Mohammad Ishraq Zafar, Feng Gao Journal: BIODRUGS, 2016, Vol.30, 255-262, DOI:10.1007/s40259-016-0177-2 DOI |
8. | A Retrospective Study on the Efficacy of Trastuzumab in HER2-Positive and Tamoxifen-Refractory Breast Cancer with Brain Metastasis Author: Chongjian Zhang, Lu Wang, Lina Wang, Shude Cui Journal: BIODRUGS, 2016, Vol.30, 33-40, DOI:10.1007/s40259-015-0156-z DOI |
9. | Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis Author: Hongmou Zhao, Hongliang Liu, Xiaojun Liang, Yi Li, Junhu Wang, Cheng Liu Journal: BIODRUGS, 2016, Vol.30, 387-396, DOI:10.1007/s40259-016-0186-1 DOI |
10. | Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis Author: Xinlin Chen, Jiangtao Hou, Yujie Yuan, Chaoyuan Huang, Tianwen Liu, Chuanwei Mo, Haiwen Li, Bin Chen, Qian Xu, Zhengkun Hou, Weiling He, Fengbin Liu Journal: BIODRUGS, 2016, Vol.30, 207-217, DOI:10.1007/s40259-016-0173-6 DOI |
|
|